Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, July 12 '25)

 


    Antiviral Res

  1. MALUNE P, Esposito F, Tramontano E
    Unveiling SARS-CoV-2's heart: role, structure and inhibition of SARS-CoV-2 RNA-dependent RNA polymerase.
    Antiviral Res. 2025 Jun 3:106208. doi: 10.1016/j.antiviral.2025.106208.
    PubMed         Abstract available

  2. LUO YS, Shen H, Ling P, Gao H, et al
    Tirofiban protects mice against severe RSV pneumonia by potentially inhibiting platelet activation via the GPIbalpha-vWF pathway.
    Antiviral Res. 2025;240:106207.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  3. FAN Z, Li J, He L, Li Q, et al
    Nanobody-based fluorescent immunoassay for SARS-CoV-2 spike detection via site-specific microbial transglutaminase labeling.
    Biochem Biophys Res Commun. 2025;775:152162.
    PubMed         Abstract available


    BMC Pediatr

  4. ANARI AM, Teymoorzadeh L, Nasiri R, Narimani S, et al
    COVID-19-associated multiple colonic perforations in a 6-month-old infant: a rare case report.
    BMC Pediatr. 2025;25:545.
    PubMed         Abstract available

  5. MACIEL GP, de Camargo R, Lopes MVV, de Oliveira BN, et al
    Sleep among Brazilian adolescents before and after the COVID-19 pandemic: repeated cross-sectional and longitudinal analyses.
    BMC Pediatr. 2025;25:541.
    PubMed         Abstract available


    Epidemiol Infect

  6. ABEYKOON AMH, Wilson M, Subbarao K, Geard N, et al
    Severe acute respiratory syndrome coronavirus-2 shedding in exhaled material: a systematic review.
    Epidemiol Infect. 2025;153:e75.
    PubMed         Abstract available


    J Clin Microbiol

  7. FALL A, Norton JM, Abdullah O, Pekosz A, et al
    Enhanced genomic surveillance of enteroviruses reveals a surge in enterovirus D68 cases, the Johns Hopkins health system, Maryland, 2024.
    J Clin Microbiol. 2025;63:e0046925.
    PubMed         Abstract available

  8. NORTON JM, Dashler G, Klein E, Mostafa HH, et al
    The utility of syndromic respiratory pathogen panels: the premise of flexible and customizable approaches.
    J Clin Microbiol. 2025;63:e0031325.
    PubMed         Abstract available


    J Gen Virol

  9. YANG T, Zhu CY, Yu PH, Yang C, et al
    Arsenic trioxide could promote SARS-CoV-2 NSP12 protein degradation.
    J Gen Virol. 2025;106.
    PubMed         Abstract available


    J Infect Dis

  10. OKABE H, Hashimoto K, Norito S, Asano Y, et al
    Amino Acid Substitutions in the Fusion Protein of Respiratory Syncytial Virus in Fukushima, Japan, During 2008-2023 and Their Effects.
    J Infect Dis. 2025;231:1544-1552.
    PubMed         Abstract available

  11. KOIRALA A, Smith K, Britton PN, Howard-Jones AR, et al
    Protracted Tuberculosis Outbreak in a Pasifika Diaspora in Western Sydney, Australia: The Importance of Community Engagement.
    J Infect Dis. 2025 Jan 9:jiae619. doi: 10.1093.
    PubMed         Abstract available

  12. WHITE CL, Richards KA, Huertas N Jr, Nayak JL, et al
    Human HKU1-Reactive CD4 T Cells Are Enriched for Cytolytic Potential That Persists in Older Adults.
    J Infect Dis. 2025;231:1591-1596.
    PubMed         Abstract available

  13. BARTSCH SM, Chin KL, Strych U, John DC, et al
    The Current and Future Burden of Long COVID in the United States.
    J Infect Dis. 2025;231:1581-1590.
    PubMed         Abstract available

  14. WALSH EE, Peasley M, Branche A, Falsey AR, et al
    Respiratory Syncytial Virus (RSV) Humoral Antibody Responses in Older Adults after Vaccination or Infection.
    J Infect Dis. 2025 Mar 24:jiaf149. doi: 10.1093.
    PubMed         Abstract available

  15. MANUELPILLAI B, Lopman B, Doran CR, Porter C, et al
    The Impact of Coronavirus Disease 2019 Nonpharmaceutical Interventions on Incidence of Acute Gastroenteritis and Acute Respiratory Infections Among US Military and Dependents.
    J Infect Dis. 2025;231:e1075-e1079.
    PubMed         Abstract available

  16. NGUYEN BT, Bertrand J, Agyeman AA, Zhang S, et al
    A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration.
    J Infect Dis. 2025;231:e1080-e1090.
    PubMed         Abstract available

  17. HEDBERG P, Serwin K, Francesca Greco M, P V Pereira J, et al
    Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19 Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project.
    J Infect Dis. 2025;231:e1091-e1101.
    PubMed         Abstract available

  18. RUMFELT KE, Juntila C, Smith M, Callear A, et al
    Strength and Durability of Respiratory Syncytial Virus Prefusion F Immunoglobulin G Following Infection and Exposure in a Household Cohort, 2014-2022.
    J Infect Dis. 2025;231:e1138-e1145.
    PubMed         Abstract available


    J Virol

  19. KANDEL S, Babujee L, Guan L, Dahn R, et al
    Phylogenetic analysis of H5N1 influenza viruses isolated from dairy cattle in Texas in December 2024.
    J Virol. 2025 Jul 8:e0058025. doi: 10.1128/jvi.00580.
    PubMed        


    Minerva Pediatr (Torino)

  20. TURRIZIANI COLONNA A, Curatola A, Sodero G, Lazzareschi I, et al
    Central precocious puberty in children after COVID-19 outbreak: a single-center retrospective study.
    Minerva Pediatr (Torino). 2025;77:306-313.
    PubMed         Abstract available


    PLoS Comput Biol

  21. JING S, Wang H
    Infectivity and fatality of influenza in pre- and post-COVID-19 pandemic year.
    PLoS Comput Biol. 2025;21:e1013229.
    PubMed         Abstract available


    PLoS One

  22. LEYVA-FLORES R, Aracena-Genao B, Allen C, Gomez-Lopez D, et al
    Examining COVID-19 vaccination coverage and acceptability among migrants in transit through Mexico during 2021-2022: Insights from shelter surveys and interviews.
    PLoS One. 2025;20:e0324325.
    PubMed         Abstract available

  23. SILVA FILHO GFD, Milhomem AB, Diniz E Silva BV, Santos KCD, et al
    Taking the opportunity of COVID testing to screen vulnerable populations for hepatitis B, hepatitis C, syphilis, and human immunodeficiency virus in Central Brazil.
    PLoS One. 2025;20:e0325859.
    PubMed         Abstract available

  24. SILVA SBT, Victor A, Gotine AREM, de Assis DM, et al
    Factors associated with death from COVID-19 in traditional peoples and communities in Brazil.
    PLoS One. 2025;20:e0327140.
    PubMed         Abstract available

  25. OLIVEIRA APC, Vieira DA, Cardoso CW, Magalhaes T, et al
    Work ability during the COVID-19 pandemic: A cross-sectional study in a low-income urban setting in Brazil.
    PLoS One. 2025;20:e0328127.
    PubMed         Abstract available

  26. LAU BH, Shum EN, Kwok AP, Liu BC, et al
    Revealing the nuances of 'Grey Digital Divide' in Hong Kong: A latent profile analysis.
    PLoS One. 2025;20:e0326413.
    PubMed         Abstract available

  27. TWOHIG FM, Baranowski TM, Ye C, Harkins M, et al
    A longitudinal assessment of the antibody response to SARS-CoV-2 infection in the New Mexican population.
    PLoS One. 2025;20:e0327698.
    PubMed         Abstract available

  28. PATEL C, Bilgin G, Hayen A, Kirk M, et al
    The association between routine immunisation and COVID-19 vaccination in small Island developing states.
    PLoS One. 2025;20:e0317327.
    PubMed         Abstract available

  29. GONZALEZ B, Mendes TP, Pinto R, Correia SV, et al
    Predictors of higher education dropout intention in the post-pandemic era: The mediating role of academic exhaustion.
    PLoS One. 2025;20:e0327643.
    PubMed         Abstract available

  30. KIKA N, Trompeter N, Lamb D, Bhundia R, et al
    Resilience during the COVID-19 pandemic: Associations with changes in burnout and mental well-being among NHS mental health staff in England.
    PLoS One. 2025;20:e0326753.
    PubMed         Abstract available

  31. PENG J, Zhang C, Li X, Tang J, et al
    Global, regional, and national burden of near vision loss in children and adolescents under 20 years from 1990-2021 and prediction to 2060: A cross-sectional study based on the global burden of disease study 2021.
    PLoS One. 2025;20:e0327000.
    PubMed         Abstract available

  32. DONZOWA J, Perrotta D, Zagheni E
    Assessing self-selection biases in Facebook-recruited online surveys: Evidence from the COVID-19 Health Behavior Survey.
    PLoS One. 2025;20:e0326884.
    PubMed         Abstract available

  33. DE ANDRADE PEREIRA SILVA M, Pelloso FC, Carvalho MDB, Oliveira RR, et al
    Effect of COVID-19 vaccination on the incidence, lethality and mortality of pregnant and postpartum women.
    PLoS One. 2025;20:e0327207.
    PubMed         Abstract available

  34. TIAN Y, Xiang W, Dzhugaryan S, Bae D, et al
    From traits to puffs: The interplay of personality, pandemic stress, and smoking behaviors.
    PLoS One. 2025;20:e0316301.
    PubMed         Abstract available

  35. RAHERINIRINA A, Tsilefa ST, Nirilanto T, Manou-Abi SM, et al
    Bayesian inference of a spatially dependent semi-Markovian model with application to Madagascar Covid'19 data.
    PLoS One. 2025;20:e0326264.
    PubMed         Abstract available

  36. BAHILLO RUIZ E, Perez-Perez L, Cardaba-Garcia RM, Durantez-Fernandez C, et al
    Relationships between fatigue severity scale (FSS)/ scale for mood assessment (EVEA) and clinical manifestations in spanish long-COVID patients.
    PLoS One. 2025;20:e0324075.
    PubMed         Abstract available

  37. MORALES I, Bueggeln J, Denzler A, Sonntag-Buck V, et al
    Performance and feasibility of self-microsampling of capillary blood and saliva for serological testing of SARS-CoV-2.
    PLoS One. 2025;20:e0327821.
    PubMed         Abstract available

  38. FRANKENTHAL D, Zatlawi M, Karni-Efrati Z, Keinan-Boker L, et al
    Evaluation of adverse events and comorbidity exacerbation following the COVID-19 booster dose: A national survey among randomly-selected booster recipients.
    PLoS One. 2025;20:e0326231.
    PubMed         Abstract available

  39. SIDDIK AB, Faisal A, Khan AH, Alam MMM, et al
    Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group.
    PLoS One. 2025;20:e0318959.
    PubMed         Abstract available

  40. ANDRADE DA, Ho-Palma A, Valdivia-Carrera CA, Munguia A, et al
    Association between self-administrated prophylactics and SARS-CoV-2 infection among traditional market vendors from the Central Highlands of Peru: A nested case-control study.
    PLoS One. 2025;20:e0327746.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  41. RAMOS KE, Nandigrami P, Najafian A, Lai JR, et al
    Optimization of a sarbecovirus llama nanobody-antigen binding interface via a combined computational and phage display protein engineering approach.
    Proc Natl Acad Sci U S A. 2025;122:e2426438122.
    PubMed         Abstract available

  42. ECKEY M, Li P, Morrison B, Bergquist J, et al
    Patient-reported treatment outcomes in ME/CFS and long COVID.
    Proc Natl Acad Sci U S A. 2025;122:e2426874122.
    PubMed         Abstract available

  43. SONI S, Yildiz S, Allen EK, Petersen H, et al
    BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza.
    Proc Natl Acad Sci U S A. 2025;122:e2424367122.
    PubMed         Abstract available

  44. YANG B, Hu A, Wang T, Chen X, et al
    SARS-CoV-2 infection induces ZBP1-dependent PANoptosis in bystander cells.
    Proc Natl Acad Sci U S A. 2025;122:e2500208122.
    PubMed         Abstract available

  45. SHANKAR V, Wilhelmy J, Curtis EJ, Michael B, et al
    Oxidative stress is a shared characteristic of ME/CFS and Long COVID.
    Proc Natl Acad Sci U S A. 2025;122:e2426564122.
    PubMed         Abstract available

  46. MEISTER TL, Nocke MK, Heinen N, Burkard TL, et al
    Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2025;122:e2500276122.
    PubMed         Abstract available


    Vaccine

  47. PIERCE SR, Shi H, Caetano C, Prots DA, et al
    Self-amplifying mRNA expressing COBRA hemagglutinin elicits long-lasting, broadly reactive antibodies against seasonal influenza A viruses.
    Vaccine. 2025;62:127449.
    PubMed         Abstract available

  48. GILROY J, O'Leary M, Domegan L, O'Connor L, et al
    Increasing the uptake of Live Attenuated Influenza Vaccine through a new school-based vaccination programme in Ireland.
    Vaccine. 2025;62:127467.
    PubMed         Abstract available

  49. LAZARUS R, Kasstan-Dabush B, Ali I, Mounier-Jack S, et al
    Influenza vaccine delivery models in secondary care (hospital) settings: What approaches are used to enhance access for clinical risk groups in England?
    Vaccine. 2025;62:127445.
    PubMed         Abstract available

  50. JIA M, Cao Y, Mu X, Ren D, et al
    School-based interventions to increase influenza vaccination in primary school students.
    Vaccine. 2025;62:127442.
    PubMed         Abstract available

  51. EDDY AC, Speaks S, Roth M, Roettger JE, et al
    IFITM3-deficient mice as a model for testing influenza virus vaccines via the intramuscular route.
    Vaccine. 2025;62:127458.
    PubMed         Abstract available

  52. ANDRAWEERA PH, Wang B, Danchin M, Blyth CC, et al
    Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccine uptake among pregnant women (EPIC study) in Australia.
    Vaccine. 2025;62:127477.
    PubMed         Abstract available

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

Stability of #influenza viruses in the #milk of #cows and #sheep

Abstract In late 2023, H5N1 high pathogenicity avian influenza (HPAIV) started circulating in dairy cattle in the USA . High viral titres were detected in milk from infected cows , raising concerns about onwards human infections . Although pasteurisation was shown to effectively inactivate influenza viruses in milk, unpasteurised milk still poses a risk of infection, both from occupational exposure in dairies and from the consumption of raw milk. We therefore assessed how long influenza viruses could remain infectious for in milk without heat inactivation. We examined the stability of a panel of influenza viruses in milk , including a contemporary H5N1 HPAIV and a variety of other influenza A and D viruses. We incubated viruses in cows' milk under laboratory conditions : at room temperature to simulate exposure in dairies and at 4°C to simulate exposure to refrigerated raw milk. Following an isolated report of H5N1 viral RNA being detected in milk from a sheep in the UK , we also c...

#Evidence of #Viremia in Dairy #Cows Naturally Infected with #Influenza A {#H5N1} Virus, #California, #USA

Abstract We confirmed influenza A virus (IAV) by PCR in serum from 18 cows on 3 affected dairy farms in California, USA . Our findings indicate the presence of viremia and might help explain IAV transmission dynamics and shedding patterns in cows. An understanding of those dynamics could enable development of IAV mitigation strategies. Source: US Centers for Disease Control and Prevention,  https://wwwnc.cdc.gov/eid/article/31/7/25-0134_article ____